| pubmed-article:12902441 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0042679 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:12902441 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:12902441 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:12902441 | pubmed:dateCreated | 2003-8-6 | lld:pubmed |
| pubmed-article:12902441 | pubmed:abstractText | Paclitaxel administered in combination with a topoisomerase-II inhibitor (such as etoposide) and carboplatin is an effective and safe first-line treatment for patients with small-cell lung cancer (SCLC). We conducted a randomized phase III multicenter trial to determine whether paclitaxel plus etoposide plus carboplatin improves the outcome of patients with primary SCLC relative to standard chemotherapy (carboplatin, etoposide, and vincristine). | lld:pubmed |
| pubmed-article:12902441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12902441 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12902441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12902441 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12902441 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12902441 | pubmed:issn | 1460-2105 | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:UlmKurtK | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:GatzemeierUlr... | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:ReckMartinM | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:KaukelEckhard... | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:von... | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:HesslerSybill... | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:BonnetReinerR | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:MachaHans-Nic... | lld:pubmed |
| pubmed-article:12902441 | pubmed:author | pubmed-author:DeppermannKar... | lld:pubmed |
| pubmed-article:12902441 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12902441 | pubmed:day | 6 | lld:pubmed |
| pubmed-article:12902441 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:12902441 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12902441 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12902441 | pubmed:pagination | 1118-27 | lld:pubmed |
| pubmed-article:12902441 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:meshHeading | pubmed-meshheading:12902441... | lld:pubmed |
| pubmed-article:12902441 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12902441 | pubmed:articleTitle | Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. | lld:pubmed |
| pubmed-article:12902441 | pubmed:affiliation | Department of Thoracic Oncology, Hospital Grosshansdorf, Hamburg, Germany. | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:12902441 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12902441 | lld:pubmed |
